drugset / Trial / NCT00651300

A Study of the Recovery Benefits After Treatment With Parecoxib/Valdecoxib in Patients Undergoing Abdominal Surgery

NCT00651300

Phase 3 Terminated 91 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate morphine intake in the first 4 hours after abdominal surgery. Morphine intake is compared between patients on placebo and patients on parecoxib/valdecoxib.

Timeline

Start
2003-04
Primary completion
Completion
2004-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Parecoxib Small molecule 40 mg Intravenous
Subject valdecoxib Small molecule 40 mg Oral

Indications

No indication recorded.